Literature DB >> 10572894

[Quality assurance in diagnostics: are there normal values for IgG-antibodies to cow's milk proteins?].

K M Keller1, A Bürgin-Wolff, R Lippold, M J Lentze.   

Abstract

BACKGROUND: The value of IgG-cow's milk antibodies is heavily disputed. Therefore, aim of the study was to establish normal values for these IgG-antibodies and to determine their diagnostic significance especially for gastrointestinal allergic manifestations. PATIENTS AND METHODS: 702 newborns were included prospectively. They received different feedings: mothers milk, cow's milk based formula and a partially or an extensively hydrolyzed formula. All children were examined annually or on occasion of allergic manifestations. An indirect immunofluorescent test was used for the assessment of IgG-antibodies against casein, beta-lactoglobulin, alpha-lactalbumin and bovine serum albumin. Values were expressed as geometric mean titers.
RESULTS: IgG-antibody titers rose slowly in the exclusively breast-fed children and peaked rapidly in the cow's milk formula-fed group, especially during the first year of life. There were no significant differences between children with and without allergic manifestations. Because of a large overlap between asymptomatic and symptomatic children it was impossible to establish normal values for the IgG-cow's milk antibodies.
CONCLUSIONS: The occurrence of IgG-cow's milk antibodies is a physiologic phenomenon without diagnostic significance. The costs of these determinations can be saved to improve process quality.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10572894     DOI: 10.1055/s-2008-1043816

Source DB:  PubMed          Journal:  Klin Padiatr        ISSN: 0300-8630            Impact factor:   1.349


  1 in total

1.  Development of a surface display ELISA to detect anti-IgG antibodies against bovine αS1-casein in human sera.

Authors:  Thorsten Saenger; Achim Braukmann; Stefan Vordenbäumen; Irina Altendorfer; Ellen Bleck; Heidrun Hochwallner; Rudolf Valenta; Matthias Schneider; Joachim Jose
Journal:  J Pharm Biomed Anal       Date:  2014-03-30       Impact factor: 3.935

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.